Latest Operational Cash Flow News

Horizon Minerals reported a $5.165 million cash outflow for Q4 2024 but bolstered its liquidity with a capital raising in January 2025, extending its runway amid ongoing exploration investments.

29Metals Limited delivered a robust December Quarter 2024 update, marked by significant operational progress including high-grade copper discoveries at Europa and a successful debt refinancing that strengthens its financial footing.

Hiremii Limited reports a modest 0.4% revenue increase to $7.5 million in Q2 FY25, underpinned by strategic AI platform deployment and expanding Energy Transition sector opportunities.

Gold Road Resources delivered record gold production and sales in the December 2024 quarter, alongside robust cash flow growth and promising exploration advances, positioning the company for an ambitious 2025.

MEC Resources has successfully completed a $2.65 million entitlement offer and resumed trading on the ASX after nearly five years of suspension. The company is now focused on advancing its energy investments, including navigating ongoing legal issues with its Advent Energy joint venture.

PARKD Ltd reports substantial structural completions on flagship projects and positive operating cash flow in Q2 FY25, setting the stage for licensing negotiations with Fielders.

Bioxyne Limited has reported a remarkable 77% jump in revenue for Q2 FY2025, alongside positive operating cash flow, as it prepares to expand manufacturing capacity and enter new international markets.

Resonance Health has reported record quarterly customer receipts of $5 million, a 57% increase from the previous quarter, alongside a major $13.8 million clinical trial contract win, signaling robust growth across its healthcare technology and clinical trial services.

Bowen Coking Coal reported a strong December quarter with record coal sales and a 39% reduction in cash costs, underpinning a $29 million EBITDA despite softer coal prices.

Energy Resources of Australia Limited reported a substantial net cash outflow of $183.9 million in Q4 2024, driven by significant rehabilitation payments, while raising $766.5 million through equity to bolster its cash position.

Bioxyne Limited reports a remarkable 77% revenue increase in Q2 FY2025 alongside positive operating cash flow, setting the stage for international growth with upcoming UK export approvals and a planned European GMP facility.

A1 Investments & Resources Ltd reported minimal cash flow activity for the December 2023 quarter while actively pursuing renewable energy acquisition opportunities in Japan and Australia.